Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

about

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

Item

http://www.wikidata.org/entity/Q38230432

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

@en

type

Item

label

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

@en

prefLabel

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

@en

P1476

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia.

@en

P2093

Alison Steinbach

http://www.w3.org/2001/XMLSchema#string

Amber B Clemmons

http://www.w3.org/2001/XMLSchema#string

Stephen M Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Second-generation tyrosine kinase inhibitors: the future of frontline CML therapy.

Evolution of therapies for chronic myelogenous leukemia.

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.

P304

451-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JADPRO.2013.4.6.8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25032026

http://www.w3.org/2001/XMLSchema#string

P932

4093452

http://www.w3.org/2001/XMLSchema#string